View in EDS

PGI18 - Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany.

Saved in:
Bibliographic Details
Title: PGI18 - Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany.
Authors: Sroczynski, G1, Conrads-Frank, A1, Kühne, F1, Mühlberger, N1, Fröhlich, H2, Dietz, B3, Samp, JC4, Zeuzem, S5, Siebert, U6
Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA512-A512. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2016.09.960